Designing Healthcare
New On Demand Dr. Nick: The Incrementalist: With guest Stacey Chang, Executive Director and Founder, Design Institute for Health and a Professor, Dell Medical School and College of Fine Arts.
Read MoreNew On Demand Dr. Nick: The Incrementalist: With guest Stacey Chang, Executive Director and Founder, Design Institute for Health and a Professor, Dell Medical School and College of Fine Arts.
Read MoreBy Anna Abram & Mark Abdoo – The European Union (EU) is one of the U.S. Food and Drug Administration’s most important collaborators in tackling public heath challenges. The FDA and the European Commission (EC) and its European Medicines Agency (EMA) have long leveraged each other’s expertise and experience…
By Gopal Khanna MBA – The COVID-19 pandemic has shown us that we need answers, now more than ever, to the complex challenges that can undercut our healthcare system’s effectiveness:
By Aaron Fulner – The COVID-19 pandemic has driven an incredible shift in the number of American lives covered by employer-sponsored health plans as unemployment creeps up to rates not seen since the Great Depression.
By Paul Grundy MD – If you know me, you know that I firmly believe “no mission, no margin.” When it comes to optimizing medication, fulfilling the mission creates the margin. You cannot divorce the two. Comprehensive medication management (CMM) is how we do it.
By Michelle McCoy – The past three years have demonstrated a collective effort to continuously improve disaster response strategies in Florida. The Emergency Census lays the foundation for other states considering how to locate missing persons once disasters strike.
In this episode of Value-Based Care Insights by Lumina Health Partners, hosts Daniel J. Marino and Shaillee J. Chopra provide commentary on Dr. George Mayzell and Doug McKinley’s webinar about physician burnout and dissatisfaction. The episode dives into pre-COVID issues, post-COVID realities, and how to create a culture of wellness.
By Stephen M. Hahn MD – One of the challenges facing the FDA during the COVID-19 pandemic is how to ensure the timely reviews of medical product applications despite a surge in volume of work and practical constraints that may impact our ability to conduct on-site inspections.
By Art Gross – COVID-19 has presented businesses with a new challenge in keeping their company safe and it starts with employee health. As they re-open in the wake of the pandemic, they must keep track of individual health with regard to who is sick and how it might affect the company as a whole.